1. Type-specific HPV and Pap test results among low-income, underserved women: providing insights into management strategies.
- Author
-
Saraiya M, Benard VB, Greek AA, Steinau M, Patel S, Massad LS, Sawaya GF, and Unger ER
- Subjects
- Adult, Cross-Sectional Studies, Early Detection of Cancer, Female, Humans, Illinois, Middle Aged, Papillomavirus Infections complications, Prospective Studies, Uterine Cervical Neoplasms virology, Uterine Cervical Dysplasia virology, Papanicolaou Test, Papillomavirus Infections diagnosis, Poverty, Uterine Cervical Neoplasms diagnosis, Vaginal Smears, Vulnerable Populations, Uterine Cervical Dysplasia diagnosis
- Abstract
Objective: The primary cervical cancer screening strategy for women over age 30 is high-risk human papillomavirus (HPV) testing combined with Papanicolaou (Pap) testing (cotesting) every 5 years. This combination strategy is a preventive service that is required by the Affordable Care Act to be covered with no cost-sharing by most health insurance plans. The cotesting recommendation was made based entirely on prospective data from an insured population that may have a lower proportion of women with HPV positive and Pap negative results (ie, discordant results). The discordant group represents a very difficult group to manage. If the frequency of discordant results among underserved women is higher, health care providers may perceive the cotesting strategy to be a less favorable screening strategy than traditional Pap testing every 3 years., Study Design: The Centers for Disease Control and Prevention's Cervical Cancer Study was conducted at 15 clinics in 6 federally qualified health centers across Illinois. Providers at these clinics were given the option of cotesting for routine cervical cancer screening. Type-specific HPV detection was performed on residual extracts using linear array., Results: Pap test results were abnormal in 6.0% and HPV was positive in 7.2% of the underserved women screened in this study (mean age, 45.1 years). HPV prevalence decreased with age, from 10.3% among 30- to 39-year-olds to 4.5% among 50- to 60-year-olds. About 5% of the women had a combination of a positive HPV test and normal Pap test results; HPV 16/18 was identified in 14% of discordant women., Conclusion: The rate of discordant results among underserved women was similar to those reported throughout the US in a variety of populations. Typing for HPV 16/18 appears to assist in the management in a small proportion of women with discordant results., (Published by Elsevier Inc.)
- Published
- 2014
- Full Text
- View/download PDF